1'-acetoxychavicol acetate has been researched along with Disease Models, Animal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Kawai, T; Kawasaki, T; Momota, M; Nagoor, NH; Okude, H; Ori, D; Sok, SPM; Wada, A | 1 |
Cho, SC; Han, SS; Kim, BH; Lee, EJ; Lee, JH; Park, DH; Park, SJ; Pyo, BS; Seo, JW | 1 |
2 other study(ies) available for 1'-acetoxychavicol acetate and Disease Models, Animal
Article | Year |
---|---|
1'-Acetoxychavicol acetate inhibits NLRP3-dependent inflammasome activation via mitochondrial ROS suppression.
Topics: Animals; Benzyl Alcohols; Caspase 1; Cells, Cultured; Disease Models, Animal; Humans; Inflammasomes; Inflammation; Interleukin-1beta; Macrophages; Mice; Mice, Inbred C57BL; Mitochondria; Monocytes; NLR Family, Pyrin Domain-Containing 3 Protein; Peritonitis; Phagocytosis; Pyroptosis; Reactive Oxygen Species; THP-1 Cells | 2021 |
1'-Acetoxychavicol acetate isolated from Alpinia galanga ameliorates ovalbumin-induced asthma in mice.
Topics: Alpinia; Animals; Anti-Asthmatic Agents; Asthma; Benzyl Alcohols; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Eosinophils; Mice; Mice, Inbred BALB C; Ovalbumin | 2013 |